Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis
- 1 September 2017
- journal article
- research article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 16 (9) , 946-950
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional studyJournal of the American Academy of Dermatology, 2016
- Positivity rates of antithyroid antibody, antinuclear antibody and thyroid peroxidase antibody in different types of vitiligoClinical and Experimental Dermatology, 2015
- Simvastatin Prevents and Reverses Depigmentation in a Mouse Model of VitiligoJournal of Investigative Dermatology, 2015
- Autoimmune thyroid disordersAutoimmunity Reviews, 2015
- CXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model of VitiligoScience Translational Medicine, 2014
- The prevalence of thyroid disease in patients with vitiligo: a systematic reviewBritish Journal of Dermatology, 2012
- A Mouse Model of Vitiligo with Focused Epidermal Depigmentation Requires IFN-γ for Autoreactive CD8+ T-Cell Accumulation in the SkinJournal of Investigative Dermatology, 2012
- VitiligoBMJ, 2010
- VitiligoNew England Journal of Medicine, 2009
- The genetics of generalized vitiligo and associated autoimmune diseasesPigment Cell Research, 2007